At a time hepatitis B programs seem to be dropping like flies, Vir Biotechnology has some good news. Its gene-silencing drug cut levels of the hepatitis B surface antigen in a small phase 2 study in ...

GSK is prioritizing development of its hepatitis B treatment bepirovirsen as the pharma ends work on another potential functional cure for the infectious disease. On a media call Wednesday morning to ...

In a recent study posted to the medRxiv* pre-print server, KU Leuven researchers investigated whether there was an association between the intensity of the co-circulation of adenovirus (AdV) 40/41 and ...

Hepatitis C is a viral liver disease spread through contact with an infected person’s blood. Due to its stealthy nature and often inadequate access to testing, many people who have hepatitis C don’t ...